CIK 0001630627
- Accelerated filer
TREACE MEDICAL CONCEPTS, INC.
Sign in to watch- Ticker
- TMCI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- Operating
- EIN
- 471052611
- Phone
- +1 904-373-5940
- Business address
- 100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
- Open-market buys, last 90 days
- $47,731
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$47,731. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-20 | Treace John T. Chief Executive Officer | Sale | −8,215 | $25.37 | $208K | 5,886,753 |
| 2021-10-20 | TIMBIE THOMAS E Director | Sale | −11,171 | $25.18 | $281K | 2,249,069 |
| 2021-10-06 | Ferguson Joe W. SVP, Research & Development | Exercise or conversion | +308,641 | $0.10 | $31K | 419,756 |
| 2021-10-06 | Ferguson Joe W. SVP, Research & Development | Exercise or conversion · Stock Option (Right to Buy) | −308,641 | 248,994 | ||
| 2021-10-01 | Hanna Betsy Director | Grant or award · Stock Option (Right to Buy) | +17,750 | 17,750 | ||
| 2021-10-01 | Jain Deepti Director | Purchase · Stock Option (Right to Buy) | +17,750 | 17,750 | ||
| 2021-09-17 | Lubben Terry W. SVP, Operations | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2021-09-07 | Treace John T. Chief Executive Officer | Grant or award | +408,816 | 408,816 | ||
| 2021-09-07 | TIMBIE THOMAS E Director | Gift | −280,000 | 2,540,240 | ||
| 2021-09-07 | TIMBIE THOMAS E Director | Gift | −280,000 | 2,260,240 | ||
| 2021-08-03 | Berutti Aaron SVP, Sales | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-04-27 | Ferguson Joe W. SVP, Research & Development | Conversion | +85,575 | 85,575 | ||
| 2021-04-27 | Ferguson Joe W. SVP, Research & Development | Other acquisition · Series A Preferred Stock | +1,981 | 85,575 | ||
| 2021-04-27 | Ferguson Joe W. SVP, Research & Development | Conversion · Series A Preferred Stock | −85,575 | 0 | ||
| 2021-04-27 | Treace John T. Chief Executive Officer | Conversion | +299,510 | 11,171,385 | ||
| 2021-04-27 | Treace John T. Chief Executive Officer | Sale | −5,253,805 | $17.00 | $89.3M | 5,917,580 |
| 2021-04-27 | Treace John T. Chief Executive Officer | Other acquisition · Series A Preferred Stock | +6,932 | 299,510 | ||
| 2021-04-27 | Treace John T. Chief Executive Officer | Conversion · Series A Preferred Stock | −299,510 | 0 | ||
| 2021-04-27 | TIMBIE THOMAS E Director | Conversion | +299,509 | 2,820,240 | ||
| 2021-04-27 | TIMBIE THOMAS E Director | Other acquisition · Series A Preferred Stock | +6,931 | 299,509 |
Page 26 of 28 · 560 trades